FutureNeuro is a new national research centre focused on chronic and rare neurological diseases, funded by Science Foundation Ireland and based at the Royal College of Surgeons in Ireland.
FutureNeuro is a new national research centre focused on chronic and rare neurological diseases. Led by Prof. David Henshall, FutureNeuro brings together multidisciplinary scientific teams with clinicians and industry to deliver advances in diagnostic medicine, personalized and network therapeutics, cross-linked by a national e-Health infrastructure platform that is disease-focused. The mission of FutureNeuro is to accelerate discoveries on genetic diagnosis and advanced molecular treatments supported by enabling e-health technology for chronic and rare neurological diseases. Building initially on internationally recognized strengths in epilepsy and motor neuron disease research, the Centre aims to develop additional research programmes in other chronic and rare neurological diseases. http://www.futureneurocentre.ie/
FutureNeuro is a new national research centre focused on chronic and rare neurological diseases. Led by Prof. David Henshall, FutureNeuro brings together multidisciplinary scientific teams with clinicians and industry to deliver advances in diagnostic medicine, personalized and network therapeutics, cross-linked by a national e-Health infrastructure platform that is disease-focused. The mission of FutureNeuro is to accelerate discoveries on genetic diagnosis and advanced molecular treatments supported by enabling e-health technology for chronic and rare neurological diseases. Building initially on internationally recognized strengths in epilepsy and motor neuron disease research, the Centre aims to develop additional research programmes in other chronic and rare neurological diseases. http://www.futureneurocentre.ie/
Examples of recent research by the group
Benefit:
- Brennan et al., Dual and opposing roles of microRNA-124 in epilepsy are mediated through inflammatory and NRSF-dependent gene networks. Cell Rep 15; 2402-12 (2016)
- Miller-Delaney et al., Differential DNA methylation profiles of coding and non-coding genes define hippocampal sclerosis in human temporal lobe epilepsy. Brain 138, 616-631 (2015)
- Brennan and Henshall., MicroRNAs in the pathophysiology of epilepsy. Neurosci Lett 667:47-52 (2018)
Benefit:
Full Funded Program
Requirement:
- At least an upper second class (2.1) honours degree in cell and molecular biology, neuroscience or similar.
- Good communication skills.
- Strong organisational and administrative skills.
- Ability to work on one’s own initiative as well as in a multidisciplinary, team environment.
- Willingness to undertake training and career development.
- English language requirements for candidates who do not speak English as their first language: an IELTS score of 6.5 or above.
- Desirable: » Previous laboratory research experience. Proven ability to work independently and as an effective team member.
The closing date for application is Friday, 4 January 2019 at 5pm GMT. The application should include:
- a cover letter outlining your interest in and suitability for the position.
- an up-to-date CV including contact details for two referees.
Deadline:
04 January 2019
Source: